DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical and Healthcare Industry in Chile – Forecast and Analysis 2022” report has been added to ResearchAndMarkets.com’s providing.
The pharmaceutical and healthcare sectors in Chile are anticipated to put up good development in the long run, with many multinational corporations trying to spend money on the nation. As of the primary half of 2021, Chile had one of many quickest COVID-19 vaccination packages on this planet, permitting the nation to go for eradicating lots of the public well being restrictions. The nation is poised for stronger financial development, and the federal government is trying to management healthcare prices by introducing drug pricing insurance policies.
The CENABAST Legislation (handed in January 2020) and the Medicine 2 invoice are anticipated to profoundly affect the Chilean pharmaceutical and healthcare sectors. The CENABAST Legislation has allowed personal pharmacy chains and impartial pharmacies to buy medicine via CENBAST. This has lowered drug acquisition prices by almost 70 %. The Medicine 2 invoice continues to be below debate and going through main backlash from the pharmaceutical trade, with the primary level of rivalry being the precise definition of the pricing system.
The Chilean pharmaceutical and healthcare trade stays a lovely sector for buyers. Added to this, the dedication of the federal government to the continued growth of public well being providers will be sure that the trade stays profitable for corporations and buyers alike.
On this trade situation, the writer presents an in-depth evaluation of the Pharmaceutical and Healthcare Business of Chile in its analysis report Pharmaceutical and Healthcare Business in Chile – Forecast and Evaluation 2022.
The report covers the next information:
- A short overview of the pharmaceutical and healthcare trade within the Americas and a snapshot of the sector throughout some main and underperforming markets of the area.
- An in-depth protection of the pharmaceutical and healthcare trade in Chile by sectors together with an evaluation of how the COVID-19 pandemic is effecting the trade.
- We analyze the segments of pharmaceuticals, generic medicine, OTC medicines, and likewise analyze the panorama for medical analysis and medical trials in Chile.
- A SWOT evaluation of the Chilean pharmaceutical and healthcare trade.
- We take an up-close view of the regulatory framework governing the Chilean pharmaceutical and healthcare trade, and the challenges being confronted when it comes to mental property rights.
- An in depth forecast of the Chilean pharmaceutical and healthcare trade by segments completes this complete evaluation.
Key Subjects Lined:
A. Govt Abstract
B. Business Definition
C. Transient View of the Americas Pharmaceutical & Healthcare Sector
D. Pharmaceutical & Healthcare Business in Chile
D.1 Impression of COVID-19 on the Business
D.2 Pharmaceutical Sector Evaluation
D.3 Healthcare Sector Evaluation
D.4 Marketplace for Prescription Medicine
D.5 Marketplace for Patented Medicine
D.6 Marketplace for OTC Medicines
D.7 Marketplace for Generic Medicine
D.8 Medical Analysis & Scientific Trials in Chile
E. Pharmaceutical & Healthcare Business in Chile: SWOT Evaluation
E.1 Strengths to Construct Upon
E.2 Weaknesses to Overcome
E.2 Alternatives to Exploit
E.4 Threats to Overcome
F. Persistent Medical Situations in Chile
F.1 Overview
F.2 Problem of Teenage Being pregnant
F.3 Most cancers
F.4 Diabetes
G. Regulatory Framework of the Business
G.1 Overview
G.2 Laws Governing Generic Medicine
G.3 Challenges with Mental Property Rights
G.4 Challenges with Counterfeit Drugs
G.5 Pricing & Reimbursement Regime
G.6 Laws Governing Advertising and marketing of Prescription drugs
H. Import/Export of Prescription drugs in Chile
I. Competitors within the Business
I.1 Aggressive Panorama
I.2 Competitors in Generic Medicine
I.3 Competitors within the Pharmacy Sector
I.4 Competitors in Drug Distribution
J. Forecast: Pharmaceutical & Healthcare Business in Chile
J.1 Outlook of the Pharmaceutical Business
J.2 Outlook of the Healthcare Business
J.3 Outlook for Prescription Medicine Sector
J.4 Outlook for Patented Medicine Market
J.5 Outlook for OTC Medication Market
J.6 Outlook for the Generic Medicine Market
Ok. Main Business Gamers
Ok.1 Laboratorios Andromaco
Ok.1.1 Company Evaluation
Ok.1.2 Enterprise Phase Evaluation
Ok.1.3 SWOT Evaluation
Ok.2 Laboratorios Chile
Ok.2.1 Company Evaluation
Ok.2.2 Enterprise Phase Evaluation
Ok.2.3 SWOT Evaluation
Ok.3 Abbott Laboratories
Ok.3.1 Company Evaluation
Ok.3.2 Enterprise Phase Evaluation
Ok.3.3 SWOT Evaluation
Ok.4 GlaxoSmithKline
Ok.4.1 Company Evaluation
Ok.4.2 Enterprise Phase Evaluation
Ok.4.3 SWOT Evaluation
Ok.5 Merck & Co. Inc. (MSD)
Ok.5.1 Company Evaluation
Ok.5.2 Enterprise Phase Evaluation
Ok.5.3 SWOT Evaluation
Ok.6 Novartis
Ok.6.1 Company Evaluation
Ok.6.2 Enterprise Phase Evaluation
Ok.6.3 SWOT Evaluation
Ok.7 Pfizer
Ok.7.1 Company Evaluation
Ok.7.2 Enterprise Phase Evaluation
Ok.7.3 SWOT Evaluation
L. Glossary of Phrases
M. Analysis Methodology
N. Disclaimer
For extra details about this report go to https://www.researchandmarkets.com/r/crbqc7.
